Eloxx Pharmaceuticals, Inc. · NASDAQ:ELOX
Stonepine Capital Management, LLC reported a 9.90% stake in Eloxx Pharmaceuticals, Inc. (Schedule 13G)
Event Jun 9, 2026 · Filed Jun 16, 2026
Stonepine Capital Management, LLC reported a 9.90% stake in Eloxx Pharmaceuticals, Inc., 403,228 shares, as a passive investor on Jun 9, 2026. Filed Jun 16, 2026 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 403,228
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Stonepine Capital Management, LLC | 9.90% | 403,228 |
| Stonepine Capital, L.P. | 9.90% | 403,228 |
| Stonepine GP, LLC | 9.90% | 403,228 |
| Jon M. Plexico | 9.90% | 403,228 |
Source
Related
- Eloxx Pharmaceuticals, Inc.
- Stonepine Capital Management, LLC
- Eloxx Pharmaceuticals, Inc. shareholders
- Schedule 13G · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Srinivas Akkaraju · Aug 14, 2026
- Schedule 13G · Domicilium Capital Partners LLC · Jun 17, 2026
- Schedule 13G · EcoR1 Capital, LLC · Jun 16, 2026
- Schedule 13G · Invus Public Equities, L.P. · Jun 15, 2026